key: cord-0991911-6egd7s61
authors: Arunkumar, Malaisamy; Gunaseelan, Sathaiah; Kubendran Aravind, Manikka; Mohankumar, Verma; Anupam, Patra; Harikrishnan, Muniyasamy; Siva, Ayyanar; Ashokkumar, Balasubramaniem; Varalakshmi, Perumal
title: Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery
date: 2021-05-20
journal: Journal of biomolecular structure & dynamics
DOI: 10.1080/07391102.2021.1921032
sha: 2e41ab8b4d5da27f0a53bc28e8aa1615c1f06d92
doc_id: 991911
cord_uid: 6egd7s61

The COVID-19 pandemic has severely destructed human life worldwide, with no suitable treatment until now. SARS-CoV-2 virus is unprecedented, resistance against number of therapeutics and spreading rapidly with high mortality, which warrants the need to discover new effective drugs to combat this situation. This current study is undertaken to explore the antiviral potential of marine algal compounds to inhibit the viral entry and its multiplication using computational analysis. Among the proven drug discovery targets of SARS-CoV-2, spike glycoprotein and 3-chymotrypsin-like protease are responsible for the virus attachment and viral genome replication in the host cell. In this study, the above-mentioned drug targets were docked with marine algal compounds (sulfated polysaccharides, polysaccharide derivatives and polyphenols) using molecular docking tools (AutoDockTools). The obtained results indicate that κ-carrageenan, laminarin, eckol, trifucol and β-D-galactose are the top-ranking compounds showing better docking scores with SARS-CoV-2 targets, than the current experimental COVID-19 antiviral drugs like dexamethasone, remdesivir, favipiravir and MIV-150. Further, molecular dynamic simulation, ADMET and density functional theory calculations were evaluated to substantiate the findings. To the best of our knowledge, this is the first report on in silico analysis of aforesaid algal metabolites against SARS-CoV-2 targets. This study concludes that these metabolites can be curative for COVID-19 in the hour of need after further validations in in vitro and in vivo testings. Communicated by Ramaswamy H. Sarma

The occurrence of viral outbreaks poses a severe threat to public health and economic loss in the present decade. In the last twenty years, viral epidemics such as SARS (severe acute respiratory syndrome) in 2002-2003, H1N1 influenza in 2009 and MERS (Middle East respiratory syndrome) in 2012 have been recorded (Cascella et al., 2021) . SARS became a global epidemic that affected more than 8000 people from 30 countries, with a mortality rate of 9.2% (WHO, 2015) , while MERS had been diagnosed with 2494 cases and caused 858 deaths, the majority are from Middle East countries especially Saudi Arabia. Both of these infectious diseases of humans were etiologically connected with coronaviruses (Drosten et al., 2003; Fouchier et al., 2003; Ksiazek et al., 2003; Marra et al., 2003; Peiris et al., 2003; Rota et al., 2003) and are listed in the priority list of pathogens (WHO, 2020b) . In late December 2019, an outbreak of respiratory illness with an unknown etiology happened in Wuhan, China, which was later diagnosed to be caused by a novel variant of coronavirus named 2019-nCoV/SARS-CoV-2 causing COVID-19 (Coronavirus infectious disease 2019) pandemic (Chen et al., 2020; WHO, 2020a) . The SARS-CoV-2 virus primarily spreads through aerosols of saliva or nasal discharges of infected persons when coughed or sneezed, and recent evidence also showed the possibility of spread by airborne transmission. Coronaviruses belong to a family of single-stranded RNA (þssRNA) viruses, found in various animal species (Perlman & Netland, 2009) , which have crown-like structure or spikes made of glycoproteins, protrudes from its envelope. SARS-CoV-2 is the biggest known RNA virus comprises a genome size of 30 kb long (Chan et al., 2013) . These spike proteins (S1 and S2 subunit) are essential to attach with the host cell receptor (ACE2) and assist virus entry inside the attached cells (International Pharmaceutical Federation, 2020; Weiss & Navas-Martin, 2005) . As of 18 th November 2020, there have been over 5,52,43,538 cases, with 13,30,930 deaths from 216 countries for the pandemic outbreak of 2019-nCoV/SARS-CoV-2 worldwide. Besides, India has crossed 88,99,163 COVID-19 cases with 131,449 deaths.

The rapid spread of SARS-CoV-2 infections is a severe global public health threat, which has gained enormous attention globally for developing medications or therapeutic strategies to curb this unprecedented pandemic disease. Despite the expeditious collaborative and extensive research efforts from the research communities across the globe, there is still no approved medication or vaccine available yet to combat this deadliest disease. Thus, there is an urgent need to find novel therapeutics or repurposing the already existing antiviral drugs to combat the SARS-CoV-2 transmission to prevent pandemics. Moreover, SARS-CoV-2 has been classified into two major lineages based on genome sequences -'L' and 'S' types, wherein 'L-type' has been evolved from 'S-type' and appears to be aggressive, highly infectious and contagious (Tang et al., 2020) . Therefore, it is highly mandatory to provide adequate protection to people to reduce the high morbidity rate globally by finding novel drugs or vaccines. The genome of SARS-CoV-2 encodes various structural proteins, including envelop (E) protein, spike (S) protein (trimeric), nucleocapsid (N) and membrane (M) proteins. Spikes proteins are one of the crucial target sites because they help viruses attach to the target cells. Spike proteins are clove-shaped, type 1-transmembrane (TM) proteins and join together in a trimeric form on the outer membrane, appearing crown-like structure and play an essential role in entering host cells. Besides the viral genome encodes a replicase complex consisting of two polyproteins PP1a and PP1b, which are processed into 16 non-structural proteins by proteases including 3CL Pro (3-chymotrypsin-like cysteine protease) and PL pro (papain-like protease) that cleaves at C-termini and N-termini of the polyproteins, respectively (Kirchdoerfer & Ward, 2019) . 3CL Pro is the crucial enzyme in viral replication and infection. Hence, spike glycoprotein and 3CL Pro have been considered as the prime targets for the treatment of SARS-CoV-2 infections. Subsequently, previously reported several inhibitors reported were repurposed against these targets, and most of them were failed to control viral infections effectively.

On the other hand, bioactive metabolites of natural origin are best suited and most consistently constructive sources for drug leads, especially products from marine sources as therapeutics are abundant. Several studies have been reported for marine antiviral drugs against HIV-1 (Human immunodeficiency virus type-1), HSV (Human herpes simplex virus), HBV (Hepatitis B virus), HCMV (Human cytomegalovirus), NoV (norovirus), RSV (respiratory syncytial virus) (Mayer et al., 2013) . Marine algae are precious natural resources that are abundant with bioactive metabolites having potential therapeutic applications, which have not been much exploited. Algal secondary metabolites in particular polysaccharides, polyphenols, terpenes, acetogenins, phlorotannins and galactans have gained much attention recently due to their extensive biological potentials. Hence, there is an excellent opportunity to discover metabolites of possible use for COVID-19. Thus, the present study explores the antiviral potential of polysaccharides, sulfated polysaccharides, sulfolipids and polyphenols from marine algae to target the SARS-CoV-2.

The conventional process of drug discovery is challenging, strenuous, costly, long and tedious. To overcome these challenges, computational tools like molecular docking has played a crucial role in rationalizing the path to drug discovery. A molecular docking methodology is currently a useful drug discovery tool that facilitates the rapid screening of candidates from drug libraries. Additionally, computational modeling of quantum chemical reaction, optimum structure and frontier molecular orbitals using density functional theory calculations are important to evaluate the molecular electrostatic potential, polarizability, dipole moment and thermal parameters of the drugs. Further, the molecular docking studies are generally validated using Molecular Dynamic simulation that evaluates the structural stability, interactions and constancy of macromolecule interactions with the ligand. The in silico ADMET profiling is widely applied in the drug-discovery process for predicting the absorption, distribution, metabolism and excretion of drug molecules which plays an important role in the screening of drugs for clinical phases.

Therefore, this investigation is mainly aimed to develop effective therapeutics using polysaccharides, sulfated polysaccharides and polyphenols to inhibit the two main protein targets of SARS-CoV-2 by molecular docking studies. Further, the efficiency of all the algal ligands interaction with the viral targets was also compared with the commercial antiviral drugs currently used against the COVID-19 pandemic.

To explore the suitable antiviral agents against SARS-CoV-2/ nCoV2, twenty-two algal compounds were chosen as ligands to interact with the two main targets (Spike glycoprotein & 3CL protease) of SARS-CoV-2. The two target proteins, Main protease(M pro )/3-Chymotripsin-like protease (3CL pro ) (PDB ID 6Y2E ) and spike glycoprotein (PDB ID 6VYB (Walls et al., 2020) ) crystal structures were downloaded from the Protein Data Bank (PDB) and HETATM (hetero atom, non-stranded residues) were removed. This spike glycoprotein has three heterotrimer polypeptide chains A chain, B chain and C chain. Among these three chains, C chain is used as the target from spike glycoprotein for the molecular docking studies. The C chain was separated from the heterotrimer chain by the Discovery Studio 2020 (Dassault System BIOVIA) visualization tool and saved as PDB format for further docking studies.

The marine algal bioactive compounds such as polysaccharides, sulfated polysaccharides (SPs), polyphenols, polysaccharide derivatives and sulfolipid were chosen as ligands for the target proteins. The ligands structures were retrieved from the PubChem database in the form of 3D structure data file (SDF), the 3D structure of the ligands with 2D SDF format were derived from the Discovery Studio 2020 visualization tool and PyMol visualization tool (Schr€ odinger, Inc.) (DeLano, 2014) . Similarly, four commercially available experimental drugs against SARS-CoV-2, such as dexamethasone, remdesivir, favipiravir and MIV-150 were also docked with the 3CL protease and spike glycoprotein as a positive control for the comparative analysis of the docking studies. The structure of the aforesaid four drugs was retrieved from the PubChem databases in the SDF format and, 3D structures were built in PyMol viewer. The collectively retrieved 3D structures in the format of PDB were further used for the docking studies. The 2D structures of all ligands are listed in Supplementary Figure 1.

Molecular docking studies were carried out using AutoDockTools (ADT) (Scripps Research US) (Morris et al., 2009) with the extension suite to the Python Molecular Viewer of MGL tools with Cygwin program (Rizvi et al., 2013) . Protein and ligand preparations were carried out in ADT. The preparation of target protein was initiated by the deletion of water, addition of polar hydrogen and merging of nonpolar hydrogen. Later the Gasteiger and Kollman charges were added to ligand and protein before the preparation of the grid parameter file, respectively. The docking studies were performed using the Lamarckian genetic algorithm (LMA) and empirical free energy function with a standard protocol (Forli et al., 2016; Rizvi et al., 2013) . The parameters of the Genetic Algorithm comprise a maximum number of 2.5 Â 10 6 energy appraisals, a maximum number of 2.7 Â 10 4 generations and a rate of mutation 0.02 with 0.8 crossover rate. Pseudo Solis & Wets parameters for local search (LS) were performed, and 300 iterations of Solis & Wets for the local search were introduced. Totally, 50 independent runs were assigned for each compound using ADT. All the structures produced from the lowest-energy structure were assigned to clusters after docking based on a tolerance of 2 Å Root Mean Square Deviation (RMSD). AutoDock program detects appropriate dockings in a protein-binding site, using LMA by starting with a ligand in an arbitrary conformation, position and orientation. Among the 50 th run, the ideal docking result was examined by the conformation with the lowest binding energy and lowest RMSD value in ADT. The protein and ligand interactions were analyzed with the hydrogen bonding, hydrophobic interactions, 2D structure interaction in the Discovery Studio tool (Biovia, 2016) .

Molecular Dynamics (MD) simulation for interaction analysis of SARS-CoV-2 main protease with selected compounds were performed using Desmond tool of Schr€ odinger Maestro platform (Schr€ odinger Release, 2019). Based on the molecular interaction and docking scores, the top-ranked compounds were selected for the Molecular Dynamics (MD) simulation analysis. The macromolecule and ligand complex was solvated using the three-dimensional orthorhombic box with a buffer distance of 10 Å and 853903 Å 3 , respectively, to build a hydration model (TIP3P water model) using System builder tool in Desmond. The water-filled box system was neutralized with counter-ions, and the addition of 150 mM of NaCl ions to mimic physiological conditions. The system energy was minimized and the macromolecule-ligand complex system was designated with the OPLS3 force field.

Next, the MD simulations were set up for 200 ns under NPT ensemble (constant number of atoms (N), constant pressure (P) and temperature (T)) where the model system was relaxed prior to simulation using the default Desmond settings. Subsequently, the MD simulations were analyzed graphically by applying a simulation interactive diagram tool that provided data on complex macromolecule-ligand properties during the simulation phase. To further substantiate the molecular docking results, RMSF (root mean square fluctuation), RMSD (root mean square distance) and bond interaction data were interpreted.

The optimum geometric structure of the ligands without imaginary frequency were developed by energy minimization and the virtual image were portrayed using Gauss view 5, Gaussian 09 software (Gaussian 09, n.d.), the basic set for the DFT calculation was carried out by B3LYP 6-311 G (d, p). The ground state-HOMO (Highest Occupied Molecule Orbital) and excitation state-LUMO (Lowest Un-occupied Molecular Orbital) of the drug were expressed in electron volt (Hartree atomic units). The energy difference between the HOMO and LUMO were measured, concurrently the electrophilicity, electronegativity, global hardness and global softness were determined by the following equation (Hagar et al., 2020) Global hardness ðgÞ ¼ À1=2 E HOMO À E LUMO ð Þ ½

(1)

2.6. In silico pharmacokinetic and toxicological properties using ADMET profiling

The in silico pharmacokinetics and pharmacodynamics evaluation of top-ranked marine algal compounds were evaluated for drug-likeness by computational ADMET profiling (Adsorption, distribution, metabolism, excretion and toxicity) using Qikprop module in Schrodinger's Maestro platform. The physicochemical descriptors were compared with the reference values of the QikProp 3.5 User Manual to predict the pharmaceutically relevant properties of the compounds (QikProp, version 3.5., Schr€ odinger).

A total of 22 naturally occurring compounds of marine algal origin consisting of non-sulfated polysaccharides, polyphenols, sulfated polysaccharides and their derivatives with the potential of antiviral, anti-microbial, anti-oxidant, anti-inflammatory and immunomodulatory activities were investigated herein for their inhibitory effects against SARS-CoV-2 targets such as spike protein and 3CL pro by molecular docking analysis. In addition, dexamethasone, remdesivir, favipiravir and MIV-150, the known antiviral drugs currently used as experimental anti-COVID-19 drugs were used as positive controls. Binding scores of the marine algal compounds are distributed within the range of À1.0 to À4.0, À4.1 to À5.0, À5.1 to À6.0, À6.1 to À7.0, À7.1 to À8.0, À8.1 to À9.0 and À14.0 to À15.0 kcal/mol ( Figure 1 ).

3.1.1. Sulfated polysaccharides Sulfated polysaccharides are heterogeneous natural polymers found abundant in marine algae, which exert a different range of pharmacological applications due to the large variability in its chemical structure and composition (Wang et al., 2018) . Sulfated polysaccharides of marine algal origin like carrageenan and fucoidan have been shown to exert antiviral activities by controlling the viral replication via blocking the binding of virions with their target cells (Baba et al., 1990) . In this study, some of the selected sulfated polysaccharides with antiviral potentials were evaluated for their binding affinity with the target proteins of SARS-CoV-2 (Figures 2-4) . Besides, the fucoidan forms the inhibitory complex with the proteins of the human hepatocellular carcinoma (HepG2) cell line and the docking score were maximum for Caspase-3 (À12.30 kcal/mol) having one hydrogen bond, NF-kappa-B (À11.57 kcal/mol) with three hydrogen bond and Cytochrome C (À9.88 kcal/mol) with one hydrogen bond (Jayameena et al., 2018) . In addition, the antiviral activity of fucoidan toward Newcastle disease virus (NDV) has been reported (Elizondo-Gonzalez et al., 2012). Similarly, carrageenan found to have a broad range of antiviral activity against herpes simplex virus, dengue virus, papillomavirus, hepatitis A virus, rhinovirus, herpes simplex virus and various enveloped viruses as influenza A virus, human immunodeficiency virus, cytomegalovirus, vesicular stomatitis virus, porcine reproductive and respiratory syndrome virus (Eccles, 2020) . Another potent sulfated compound, sulfoquinovosyl diacylglycerol (SQDG) are a class of sulfolipids containing glycolipids with sulfur, found in algae and other photosynthetic organisms. SQDG isolated from various algal species exhibits potent antiviral activity, particularly against HIV-1 with cytopathic effect inhibition, HSV-2 (selectively inhibiting replication), antitumor-promoting properties and moderate antiviral against HSV-1 and Coxsackievirus B3 (Cox B3) (De Souza et al., 2012; Gustafson et al., 1989; Plouguern e et al., 2013; Shirahashi et al., 1993) . SQDG from red alga Gigartina tenella primarily acted on HIV-1 by inhibiting DNA polymerase a and b and HIV-RT (HIV-reverse transcriptase type 1) (Ohta et al., 1998) .

These findings of in silico studies are strong evidence for the potential antiviral properties of these sulfated polysaccharides against SARS-CoV-2 because of their promising interaction with spike glycoprotein and 3CL pro . Moreover, it is noteworthy to mention that the presence of polysulfates on sulfated polysaccharides results in a highly negative charge that would facilitate the interaction with viral spike glycoproteins due to the presence of positively charged ions on its surface (Damonte et al., 2012) . Sulfated polysaccharides against HIV and HSV have been widely used, but it is not yet tested against SARS-CoV-2. Also, sulfated polysaccharides are attracting molecules that can able induce diverse immune cells and also have the ability to act as an adjuvant for treating immunological disorders (Bi et al., 2018; Mei et al., 2017) . Furthermore, sulfated polysaccharides from various natural resources had exerted intense immunomodulatory activity by inducing the macrophages to secrete the cytokines (Barbosa et al., 2019) , which is highly essential to maintain the secretion of cytokines in SARS-CoV-2 infected individuals.

The present study revealed a noticeable interaction of alpha-carrageen, carrageen-lambda and 3,6-anhydro-D-galactose-2-sulfate with the spike glycoprotein were observed ( Figure 5 ). Among the twenty-two ligands, the j-carrageenan had shown the best highest binding energy (À14.37 kcal/ mol) and lower inhibition constant (Ki ¼ 29.35 pM) (Table  1a ,b) with 3CL pro interaction compared to the commercial antiviral drugs dexamethasone, remdesivir, favipiravir and MIV-150. Likewise, ß-carrageenan showed higher binding affinity with 3CL pro compared to remdesivir and favipiravir. Additionally, j-carrageenan, carrageenan-lambda, ß-carrageenan, sulfoquinovosyl diacylglycerol and fucoidan showed even better docking scores with spike glycoprotein compared to that of all positive controls (antiviral drugs). Thus j-carrageenan, ß-carrageenan and carrageenan-lambda may be used as an antiviral drugs to prevent the multiplication of the virus in the host cells, once after conducting the preclinical studies to validate its potential further. 

In the recent scenario, many investigations are being carried out to exploit the marine algae as the richest source of bioactive metabolites for treating communicable and noncommunicable diseases. Polysaccharides abundantly synthesized from algae are considered non-toxic, cheap, safe, biocompatible and biodegradable (Ahmadi et al., 2015) . Also, these polysaccharides are being commercially produced in pharmaceutical industries for its wider applications. In this context, some of the potential non-sulfated polysaccharides structures exclusively from algae were retrieved from the PubChem database and have been used for molecular docking studies with the selected targets of SARS-CoV-2. Interestingly, the docked results attained from AutoDockTools had revealed that the top-ranking ligand was laminarin based on the highest binding energy, lower Ki and highest hydrogen bonds with both spike glycoprotein and 3CL pro of SARS-CoV-2 (Table 2a,b) . Laminarin is found in brown algae, which is a storage glucan of linear polysaccharide consisted of b-1,3 linkage with glucose and b-1,6 linkage in side-chain branching. Laminarin is exploited for several antiviral potentials against HIV, works by inhibiting the reverse transcriptase mechanism leading to non-proliferation of the virus. And this is the first to report to dock laminarin with SARS-CoV-2 3CL Pro . b-glucan also resulted in a strong binding affinity with 3CL Pro . b-glucans are structural non-starch polysaccharides consisting of b-D-glucose monomer units holding by glycosidic linkages. b-glucans are obtained from brown algae cell walls such as Laminaria sp. and also extracted from bacteria, fungi and lichens. b-glucan has hypoglycemic, prebiotic, anticancer, antihypertensive, wound healing, immune-boosting, antiviral and antibacterial properties (Kaur et al., 2020; Raimundo et al., 2017) . b-glucan from Aspergillus brasiliensis has been exploited for antiviral potential against bovine herpesvirus (BoHV-1) and the inhibition of viral replication has been demonstrated by plaque assay (Minari et al., 2011) . Besides, b-glucans have multifunctional features, including host defense mechanisms, enhancing the immune response, T-cell activation, anti-inflammatory and also can bind to macrophages and other polymorphonuclear cells (Gantner et al., 2003; Herre et al., 2004; . Moreover, it is well known that the immune functions such as secretion of cytokines (IL-1, IL-6 and GMCSF), phagocytosis, interferons and antigen processing are improved when the b-glucan receptor is occupied with b-1,3/1,6 glucan (Meena et al., 2013) . Previously, it has been reported that b-1,3-glucan interacts with the dectin-1 enzyme, which plays an important role in tumor cell-associated glycosylation. The tumor cells show excess production of dectin-1 and also stated that it plays a vital role in activating immunological responses by interacting with b-1-3 glucan. The Dectin-1 is a transmembrane protein (type II) present on leukocytes surface, showed the highest levels of cell surface expression in macrophages, neutrophils and dendritic cells (Chiba et al., 2014) . Similar effects of b-glucan on immunological response activation may be effective in immune-compromised patients with COVID-19.

Next to laminaran, b-glucan and alginate had shown a promising interaction with both spike glycoprotein and 3CL pro (Figures 6-8) . Alginates are comprised of poly-D-glucuronic acid and poly-D-mannuronic acid (Mabeau & Kloareg, 1987; Wang et al., 2012) that are present majorly in the brown algae Laminaria japonica, Ascophyllum nodosum, Laminaria digitata and Laminaria hyperborean. These are acidic polysaccharides comprise various biomedical applications especially used as an immune activator, and importantly the antiviral potential of alginate as 911 drug has also been reported against HIV as reverse transcriptase inhibitor and blocking the DNA polymerase activity in Hepatitis B virus (HBV) (Xianliang et al., 2000) . Recently it has also been reported that by alginate supplemented therapy immune tolerance can be enhanced in COVID-19 patients (El-Sekaily et al., 2020) .

Hence, the above-mentioned report of polysaccharides are exploited as antiviral drugs against the enveloped viruses, and these evidence are substantiated with the in silico analysis performed in this study for the aforesaid polysaccharides.

Additionally, algal polysaccharides and sulfated polysaccharides were reported to have antiviral activity for various enveloped viruses herein the derivatives of sulfated polysaccharides were also included for in silico analysis. The carbohydrates and its derivatives are involved in various processes and pathways of marine organisms survival in the harsh marine environment. Some sulfated polysaccharide derivatives of red seaweed possess selective antiviral properties against HSV-1 and HSV-2 (Duarte et al., 2004) . Moreover, red algae Acanthophora spicifera derivatives block the virus entry by interfering with the initial attachment of the virus to the target cell. However, the antimicrobials from the non-sulfated carbohydrates are scarce. Thus, this study would specifically emphasize the interaction with the derivatives of polysaccharides and sulfated polysaccharides from algae, which were retrieved from PubChem, examined by molecular docking and the comparative binding scores of ligands with the two targets of SARS-CoV-2 were depicted in Figures 9-12 . Interestingly all the ligands used in this docking experiment had shown the interaction with some specific amino acid of the targets like Glu166, Gln189, Cys145, Phe140. In addition, almost all the derivatives of polysaccharides have shown the interaction with 3CL pro and spike glycoprotein with high binding energy, low Ki and higher hydrogen bonds. It is noteworthy to mention that b-galactan ranks first when compared with all other derivatives of polysaccharides because of the higher binding energy with 3CL pro and spike glycoprotein (À8.26 and À6.24 kcal/mol) followed by b-1,3galactotriose, galactobiose, b-1,6-galactotriose and dialphaGal, which also showed best binding energy and Ki with both the targets (Table 3a,b) .

The chemical description of the compounds is as follows: b-1,6-galactotriose and b-1,3-galactotriose belongs to the class of organic compounds known as oligosaccharides. b-1,3-galactotriose is a derivative of lambda-carrageenan; a trisaccharide composed of three b-D-galactose units joined by (1!3)-linkages whereas, b-1,6-galactotriose are joined by (1!6)-linkages (Lawson & Rees, 1968) . Galactobiose is also called as b-D-galactopyranosyl-1,4-b-D-galactopyranose, and these are derivatives of j-carrageenan (O Neill, 1955) . Galactotriose is a trisaccharide consists of three hexose carbohydrate units linked to each other through glycosidic bonds, it is also a type of laminarin which serves as a storage glucan in brown algae (Dictionary of Food Compounds with CD-ROM, 2013). b-galactan is a polysaccharide consisting of polymerized galactose residues joined by b-(1!4)glycosidic linkages found in red seaweeds (Delattre et al., 2011) . 3,6-anhydro-D-galactose is a constituent of a sulfated polysaccharide j-carrageenan obtained from red macroalgae. This j-carrageenan consists of an alternating backbone of D-galactose-4-sulfate and 3,6-anhydro-D-galactose (Kim & Lee, 2016) . DialphaGal is a glycosylgalactose that constitutes two units of D-galactose linked by a-(1!3) linkage, which can act as an epitope or antigen. This is also intrinsic to the chemical structure of carrageenan. It is also primarily found in mammals excluding humans; it's derivative a-Gal epitope that is considered as a vaccine candidate for HIV infection since it can induce antibodies in the system. It has been reported that a-Gal hinder human visceral and cutaneous leishmaniasis (Moura et al., 2017) and defend malarial infection (Yilmaz et al., 2014) . However, antiviral activity has not been reported so far for the foresaid carbohydrates. Thus, this study necessitates the in vitro and in vivo testing of these compounds since they had exhibited good interaction with the viral targets of SARS-CoV-2 over the commercial antiviral drugs and to unveil the mechanism of antiviral potential in the near future.

Phlorotannins are classified under the polyphenolic compounds that are being considered as a suitable candidate for treating communicable and non-communicable diseases and their efficacy at the molecular level have not been elucidated in detail so far. Phlorotannins are secondary metabolites derived from brown algae, which are formed by polymerization of phloroglucinol monomer (1,3,5-trihydroxybenzene) through either ether, phenyl or 1,4-dibenzodioxin linkages. Phloroglucinol has been reported for anti-allergic, antiinflammatory, anti-microbial, antioxidant and antiviral activities. It has also been reported to inhibit the reverse transcriptase and protease activities of HIV-1 (Kang et al., 2006) . Besides, 8,8 0 -bieckol is an eckol type of phlorotannin that also has the efficiency in inhibiting the reverse transcriptase activity in HIV-1 (Ahn et al., 2004) . Eckol extracted from the brown alga Ecklonia cava, has been used as a tyrosinase inhibitor and docking of the tyrosinase-ligand complexed with eckol exhibited binding energy of À115.84 kcal/mol and found that eckol interacts with Asn205, His208 and Arg209 (Lee et al., 2015) . Eckol was also identified as a possible therapy for neurodegenerative disorders targeting receptors of dopamine D3/D4. Eckol interacted hD3R with a binding energy (-6.41 kcal/mol), five H-bond interactions and hD4R with binding energy of (À6.46 kcal/mol), while the dopamine showed binding energy (-5.68 kcal/mol). This less binding energy may be due to four H-bond interactions, and eckol also formed hydrophobic and electrostatic interactions (Paudel et al., 2019) .

Therefore, this study also explored the antiviral potentials of algal polyphenols like phloroglucinol, eckol, difucol and trifucol by computational analysis using the targets of SARS-CoV-2 (Figures 13 and 14) . Similar to the above-mentioned results, eckol showed strong interaction with 3CL pro with a higher binding energy of À8.19 kcal/mol with lower Ki of 993.73 nM (Table 4a) , as compared to the docking score of COVID-19 experimental antiviral drugs such as dexamethasone, remdesivir, favipiravir and MIV-150. This result is clearly suggesting that eckol might be a promising drug for the treatment of COVID-19. Further, next to eckol the highest binding energy was obtained from trifucol with both the targets spike glycoprotein (À7.5 kcal/mol) and 3CL pro (À6.3 kcal/mol), respectively (Table 4b and Figure 15 ). The other two ligands difucol and phloroglucinol had also shown good interaction with both the targets but whose biding energy and Ki are comparatively less to trifucol, eckol, dexamethasone and MIV-150.

The antiviral potency of ligands through molecular docking is further validated by comparing the docking score of antiviral drugs (as positive controls), namely dexamethasone, remdesivir, favipiravir and MIV-150 by computational analysis. MIV-150 is reported as an anti-retroviral drug that is prepared with carrageenan as a drug delivery compound that can inhibit reverse transcriptase activity of HIV-1 (Singer et al., 2011) . Among the positive controls, MIV-150 showed the highest binding energy with both spike glycoprotein and 3CL pro of SARS-CoV-2 with the lowest Ki and highest hydrogen bond (Figures 16 and 17) , whereas the interaction with the spike glycoprotein is relatively lesser than the 3CL pro . And among the antiviral drugs used MIV-150 tops the chart with higher binding affinity and lower Ki with both targets. Though it had been successful against other viral diseases, there is still no study on MIV-150's effect on SARS-CoV-2 both in vitro, in vivo and this is the first study to report MIV-150 against SARS-CoV-2 in silico. Therefore, this antiviral could be implemented for COVID-19 clinical trials since it had shown better docking scores as compared to recently tested anti-COVID-19 drugs dexamethasone, favipiravir and remdesivir.

Favipiravir (6-fluoro-3-hydroxy-2-pyrazine carboxamide) is reported as a broad-spectrum antiviral agent against different RNA viruses as it has the potential to inhibit the RNA-dependent RNA polymerase (RdRp) of RNA viruses (Furuta et al., 2017) . Favipiravir has also shown good efficiency against influenza and Ebolavirus (Furuta et al., 2013; NIH, 2020; Oestereich et al., 2014) . Recently, it was reported that favipiravir and remdesivir are potentially active and reducing the SARS-CoV-2 infection in vitro (EC 50 ¼ 61.88 lmol/L, CC 50 > 400 lmol/L, SI > 6.46) . Additionally, favipiravir has been approved in Japan against novel epidemic influenza strains (Shiraki & Daikoku, 2020) . In our study, the favipiravir showed a moderate interaction ( Figure 18 ) with the targets and the highest hydrogen bond was observed in the interaction with 3CL pro and spike glycoprotein. Remdesivir is a drug and used as a potent antiviral drug and reported to be effective against lethal Nipah and Ebola virus infections in nonhuman primates (Lo et al., 2019) . It inhibits the replication of coronaviruses in respiratory epithelial cells, and the results obtained from this study indicate that the best binding energy and highest hydrogen bond with the targets of SARS-CoV-2 by remdesivir (Lo et al., 2019) . Recently, dexamethasone is also been widely accepted as an antiviral drug for the treatment of COVID-19 patients. Dexamethasone was also used as a ligand for this study to perform the molecular docking with the SARS-CoV-2 targets. The results indicate that dexamethasone is a promising drug showing the highest binding energy with 3CL pro , whereas its interaction with the spike glycoprotein is lesser (Table 5a,b) .

Hence, the selected commercial antiviral drugs used for this in silico analysis had evidenced that the strong interaction with 3CL Pro , which is highly essential for viral replication. Similarly, the ligands chosen from algal sources had also shown promising interaction with 3CL Pro and spike glycoprotein than above-stated commercial antiviral drugs. Interestingly, we have observed that almost all the ligands had interacted by sulfuryl derivative and hydroxyl side chain with the targets of SARS-CoV-2. To the best of our knowledge, this is the first report to analyze the SARS-CoV-2 main target proteins binding affinity with b-galactan, alginate, galactotriose, b-(1,6)-galactotriose, 3,6-anhydro-D-galactose, b-galactan, dialphagal, b-(1-3)-galatotriose, galactobiose, a-carrageenan, 3,6-anhydro-D-galactose-2-sulfate, sulfoquinovosyl diaceylglycerol, difucol, trifucol and MIV-150.

Hence, this study would shed light on the discovery of potent biocompatible polysaccharides and its derivatives from algae as promising drug candidates against the severe COVID-19 pandemic. Further, this study proposes that these top-ranked bioactive compounds can be taken to next level of in vitro and preclinical studies to substantiate their potency in this crisis of search for antivirals. 

To further validate the molecular docking findings, the MD simulation was performed for the SARS-CoV-2 main protease with selected lead marine algal compounds to evaluate the structural stability and constancy of macromolecule interactions with the ligand by Desmond tool. MD simulation system was prepared for 3CL pro of SARS-CoV-2 with potent marine algal inhibitors to find out the strong interactions based on hydrogen bonds, hydrophobic, ionic and water bridges. The MD simulation provides information on the position and distance patterns of the interacting amino acids to build a stable inhibition complex. In Figure 19 , the Root Mean Square Deviation (RMSD) value is shown from the simulation results. The changes of RMSD value throughout the simulation time for both the ligand and the macromolecule were around 3 Å, which testify the stability of the complex. The Root Mean Square Fluctuation (RMSF) of the macromolecule-ligand complex is illustrated in Figures 20  and S4 . In an efficient macromolecule-ligand association, a combination of all the interactions in the allosteric site profoundly supports a stable strong interaction. In Figure S3 all interactions across the simulation are shown such as proteinligand contacts timeline, protein secondary structure elements (SSE) like alpha-helices and b-strands which were monitored throughout the simulation.

In simulation studies, the ligand-macromolecule complex maintained a stable interaction, which should present at least 30% of the total simulation time. Eckol showed polar interaction with Asn 142 at 33% of simulation time; while charged interaction with Glu 166 was 59% of the simulation time. Here, Glu 166 exhibited the highest number of hydrogen bonds as well as water bridges. Similarly, in b-galactan, ligand-interaction patterns showed the polar contacts with Gln 192, Thr 190 and His 64, where the interaction time was 61%, 41% and 64%, respectively. Here also, along with polar contacts, charged contacts on Asp 187 and Glu 166 displayed 48% and 73% of total interaction time, respectively. Among all simulation results, Glu 166 showed the highest number of hydrogen bonds with water bridges and conserved in all dynamics studies than Gln 189. So, among the total interaction, Glu 166 and Gln 189 held a strong binding affinity to the ligands. An adequate protein-ligand association indicated a stable complex formation, in sight of all the interaction in the allosteric region. Further, in vitro and in vivo validations of these algal compounds are needed to prove its efficacy against COVID-19 in near future.

DFT analysis can render valuable insights into the structure-activity relation of molecules by analyzing the molecular structure using the energies of their molecular orbitals (Geerlings et al., 2020) . The conceptual prediction of structural and iso-density properties of the compounds was given in Figure S5 . Since the electron transfer mechanism is one of the fundamental phenomena for the enzymatic reactivity. The frontier orbital was determined by the energy gap between the highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) of the compounds. The HOMO indicates the electron donor properties, whereas the LUMO indicates electronaccepting properties. Recently, quantum chemical calculation has been used to investigate the structural properties and realistic potential of the compounds against biomolecules. The energy level of the ground state and excitation state of the molecules were tabulated in Table 6 . The DE is comparatively lower in j-carrageenan (1.47 eV), whereas the higher energy gap of the investigated compound was b-1,3-galactotriose (7.02 eV). However, the other compound also exhibits almost the same level of energy gap shown in Figure 21 . Additionally, the global hardness, softness electronegativity and electrophilicity were also examined to investigate the cell permeability of the molecules (Majumdar et al., 2020) . Especially, global softness is one of the important criteria that facilitate the permeability of mammalian cells. The j-carrageenan possessed higher softness and electrophilicity as compared with other compounds (Table 6 ). These results suggest that the binding affinity of the drug toward electrocharged biomolecules could efficiently interact in the aspect of a quantum chemical reaction.

To further validate the marine algal compounds for drug-likeliness, the parameters such as absorption, distribution, metabolism, excretion and toxicity (ADMET) profile were investigated. ADMET properties are consideredto be the crucial parameters for drug-likeness evaluation in the early drug discovery process. The major two determinants such as solubility and permeability are very important in the metabolism of drugs. In the present study, the prediction of ADMET, pharmacokinetics, drug-likeness properties of the marine algal compounds was evaluated in silico by Schrodinger's QikProp module. The ADMET studies were performed for the ligand molecules which exhibited higher potential inhibition against 3CL protease and spike protein of SARS-CoV-2. The major ADMET properties for drug-likeness were predicted (serially numbered in Tab. 7) such as 1. molecular weight of the molecule (mol_MW); 2. dipole moment of the molecule; 3, 4. Estimated number of hydrogen bonds that would be accepted/ donated by the solute from/to water molecules in an aqueous solution (donorHB/accptHB); 5. Predicted polarizability in cubic angstroms (QPpolrz); 6. Predicted water/gas partition coefficient (QPlogPw); 7. Predicted octanol/water partition coefficient (QPlogPo/w); 8. Predicted aqueous solubility (QPlogS); 9. Predicted IC 50 value for blockage of HERG K þ channels (QPlogHERG); 10. Predicted apparent Caco-2 cell permeabilitymodel for the gut-blood barrier (QPPCaco); 11. Predicted brain/ blood partition coefficient (QPlogBB); 12. Predicted skin nitrogen atoms (PSA); 18. The number of violations of Lipinski's rule of five (RuleOfFive) and compounds with mol_MW < 500, QPlogPo/w < 5, donorHB 5, accptHB 10 are considered druglike; 19. Number of violations of Jorgensen's rule of three (RuleOfThree). The compounds with lower violations of the following parameters such as QPlogS > À5.7, QP PCaco > 22 nm/ s, # Primary Metabolites < 7 are more likely to be orally available; 20. Predicted maximum transdermal transport rate (Jm). The results obtained were compared with the reference values of the QikProp 3.5 User Manual to predict physically significant descriptors and pharmaceutically relevant properties of organic molecules (QikProp, version 3.5., Schr€ odinger).

The top-ranked marine algal compounds (b-(1-6)-galactotriose, b-(1-3)-galactotriose, eckol, b-glucan and laminarin) from molecular docking studies satisfied most of the druglike properties and ADMET profile. Especially 4 out of 6 ligands exhibited great scope in rules of five and rules of three. The b-(1-6)-galactotriose, b (1-3)-galactotriose and laminarin ligand molecules were in the recommended range at 3 in the rule of five and greater than 1 in the rules of three thus revealing promising drug-likeliness property as well imitating as equivalent to commercially available drugs. Other major characteristic features like human oral adsorption, cell permeability, metabolic reaction index, skin permeability, blood-brain barrier and partition co-efficiency were seemed to be of greater value which substantiates the drug-like behavior of the ligand molecules which can be considered as algal lead compounds against COVID-19. Thus, it can be concluded that these compounds can be taken up for the next level of in vivo and preclinical investigations in order to prove their efficacy against SARS-CoV-2 infection. 

The computational approaches for virtual screening of the natural compounds of marine algae retrieved from the PubChem database were docked with the spike glycoprotein and 3CL pro of the novel SARS-CoV-2 to investigate the ability of the compounds to block the entry of the virus by preventing the attachment and its replication. The docking results attained are strongly suggesting that the algal sulfated polysaccharides, polysaccharides derivatives and polyphenols exhibited a better interaction with both targets of SARS-CoV-2 when compared to commercial leading antiviral drugs against COVID-19. Moreover, the validations of the lead marine algal compounds obtained from molecular docking were further substantiated by molecular dynamic simulation, DFT calculations and ADMET profiling. Therefore, based on the mechanism of interaction of these ligands with the viral targets, it can be further evaluated by conducting in vitro and clinical studies to confirm their antiviral activity against SARS-CoV-2 and these compounds would be suitable drug candidates for the treatment of the COVID-19 pandemic situation in near future. 

Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing a-gal epitopes

Antiviral potential of algae polysaccharides isolated from marine sources: A review

Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava

Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation

Immune activation of RAW264.7 macrophages by low molecular weight fucoidan extracted from New Zealand Undaria pinnatifida

Discovery Studio Modeling Environment

Features, evaluation and treatment coronavirus (COVID-19). In StatPearls

Interspecies transmission and emergence of novel viruses: Lessons from bats and birds

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study

Recognition of tumor cells by Dectin-1 orchestrates innate immune cells for anti-tumor responses

Sulfated seaweed polysaccharides as antiviral agents

Structural characterization and anti-HSV-1 and HSV-2 activity of glycolipids from the marine algae Osmundaria obtusiloba isolated from Southeastern Brazilian coast

The PyMOL Molecular Graphics System, Version 1.8. Schr€ odinger LLC

Galactans: An overview of their most important sourcing and applications as natural polysaccharides

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

The structure of the agaran sulfate from Acanthophora spicifera (Rhodomelaceae, Ceramiales) and its antiviral activity. Relation between structure and antiviral activity in agarans

Iota-carrageenan as an antiviral treatment for the common cold

In vitro characterization of the antiviral activity of fucoidan from Cladosiphon okamuranus against Newcastle Disease Virus

Enhancement of immune tolerance of COVID-19 patients might be achieved with alginate supplemented therapy

Computational protein-ligand docking and virtual drug screening with the AutoDock suite

Koch's postulates fulfilled for SARS virus

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase

Accelerated healing of skin burns by anti-Gal/a-gal liposomes interaction

Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2

Conceptual density functional theory: Status

AIDS-antiviral sulfolipids from cyanobacteria (Blue-Green Algae)

Investigation of some antiviral N-heterocycles as COVID 19 drug: Molecular docking and DFT calculations

Dectin-1 and its role in the recognition of b-glucans by macrophages

Coronavirus SARS-CoV-2/COVID-19 pandemic: Information and Guidelines for Pharmacists and the Pharmacy Workforce

Nitric Oxide Synthase and Cytochrome C)

Cytoprotective effect of phloroglucinol on oxidative stress induced cell damage via catalase activation

Structural features, modification, and functionalities of beta-glucan. Fibers

Production of 3,6-anhydro-D-galactose from j-carrageenan using acid catalysts

Algae-derived b-glucan enhanced gut health and immune responses of weaned pigs experimentally infected with a pathogenic E. coli

PubChem 2019 update: Improved access to chemical data

Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors

A novel coronavirus associated with severe acute respiratory syndrome

Reinvestigation of the acetolysis products of k-carrageenan, revision of the structure of "a-1,3-galactotriose," and a further example of the reverse specificities of glycoside hydrolysis and acetolysis

Cellular activities and docking studies of eckol isolated from Ecklonia cava (Laminariales, Phaeophyceae) as potential tyrosinase inhibitor

In vitro and in vivo immunomodulatory activity of sulfated polysaccharide from Porphyra haitanensis

Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge

Isolation and analysis of the cell walls of brown algae: Fucus spiralis, F. ceranoides, F. vesiculosus, F. serratus, Bifurcaria bifurcata and Laminaria digitata

DFT investigations of linear Zn3-type complex with compartmental N/O-donor Schiff base: Synthesis, characterizations, crystal structure, fluorescence and molecular docking

The genome sequence of the SARS-associated coronavirus

Marine pharmacology in 2009-2011: Marine compounds with antibacterial, antidiabetic, antifungal, anti-inflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action

B-glucan: An ideal

Antiviral properties of polysaccharides from Agaricus brasiliensis in the replication of bovine herpesvirus 1

Autodock4 and AutoDockTools4: Automated docking with selective receptor flexibility

Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults -T705US316

Derivatives of 4-O-b-D-Galactopyranosyl-3,6-anhydro-D-galactose from k-Carrageenin

Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model

Sulfoquinovosyldiacylglycerol, KM043, a new potent inhibitor of eukaryotic DNA polymerases and HIV-reverse transcriptase type 1 from a marine red alga, Gigartina tenella

Eckol as a potential therapeutic against neurodegenerative diseases targeting dopamine D3/D4 receptors

Coronavirus as a possible cause of severe acute respiratory syndrome

Coronaviruses post-SARS: Update on replication and pathogenesis

Antiviral sulfoquinovosyldiacylglycerols (SQDGs) from the Brazilian brown seaweed Sargassum vulgare

b-1,3-Glucans are components of brown seaweed (Phaeophyceae) cell walls

A simple click by click protocol to perform docking: AutoDock 4.2 made easy for non-bioinformaticians

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

Desmond molecular dynamics system

Isolation and identification of anti-tumor-promoting principles from the fresh-water Cyanobacterium phormidium tenue

Favipiravir, an anti-influenza drug against life-threatening RNA virus infections

The nonnucleoside reverse transcriptase inhibitor MIV-150 in Carrageenan gel prevents rectal transmission of simian/human immunodeficiency virus infection in macaques

On the origin and continuing evolution of SARS-CoV-2

Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

The antiviral activities and mechanisms of marine polysaccharides: An overview

Sulfated modification of polysaccharides: Synthesis, characterization and bioactivities

Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus

WHO j Update 79 -Situation in China

Prioritizing diseases for research and development in emergency contexts

Study on the mechanism of inhibitory action of 911 on replication of HIV-1 in vitro. Zhongguo hai Yang yao wu¼

Gut microbiota elicits a protective immune response against malaria transmission

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors

The authors thank the Department of Biotechnology (DBT), New Delhi, India for the financial support, DST-FIST, DST-PURSE, University Grant Commission (UGC)-SAP, UGC-UPE program of MKU for the infrastructure, instrumentation facility and International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi for Molecular dynamic simulation and ADMET studies using Schrodinger software.

The authors declare no conflict of interest.

The authors thank the Department of Biotechnology (DBT), New Delhi, India (No: BT/PR15677/AAQ/3/799/2016), for the financial support to PV.

http://orcid.org/0000-0002-5420-4688